Annual D&A
$877.00 K
+$552.00 K+169.85%
December 31, 2023
Summary
- As of February 7, 2025, TARS annual depreciation & amortization is $877.00 thousand, with the most recent change of +$552.00 thousand (+169.85%) on December 31, 2023.
- During the last 3 years, TARS annual D&A has risen by +$781.00 thousand (+813.54%).
- TARS annual D&A is now at all-time high.
Performance
TARS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$284.00 K
+$45.00 K+18.83%
September 30, 2024
Summary
- As of February 7, 2025, TARS quarterly depreciation & amortization is $284.00 thousand, with the most recent change of +$45.00 thousand (+18.83%) on September 30, 2024.
- Over the past year, TARS quarterly D&A has dropped by -$63.00 thousand (-18.16%).
- TARS quarterly D&A is now -18.16% below its all-time high of $347.00 thousand, reached on December 31, 2023.
Performance
TARS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.14 M
+$40.00 K+3.64%
September 30, 2024
Summary
- As of February 7, 2025, TARS TTM depreciation & amortization is $1.14 million, with the most recent change of +$40.00 thousand (+3.64%) on September 30, 2024.
- Over the past year, TARS TTM D&A has increased by +$263.00 thousand (+29.99%).
- TARS TTM D&A is now at all-time high.
Performance
TARS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TARS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +169.8% | -18.2% | +30.0% |
| 3 y3 years | +813.5% | -18.2% | +30.0% |
| 5 y5 years | +10000.0% | -18.2% | +30.0% |
TARS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +181.1% | -18.2% | +610.0% | at high | +345.3% |
| 5 y | 5-year | at high | +2270.3% | -18.2% | +1793.3% | at high | +7500.0% |
| alltime | all time | at high | >+9999.0% | -18.2% | +1793.3% | at high | +7500.0% |
Tarsus Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $284.00 K(+18.8%) | $1.14 M(+3.6%) |
| Jun 2024 | - | $239.00 K(-11.5%) | $1.10 M(+5.5%) |
| Mar 2024 | - | $270.00 K(-22.2%) | $1.04 M(+18.9%) |
| Dec 2023 | $877.00 K(+169.8%) | $347.00 K(+42.2%) | $877.00 K(+39.6%) |
| Sep 2023 | - | $244.00 K(+34.1%) | $628.00 K(+31.4%) |
| Jun 2023 | - | $182.00 K(+75.0%) | $478.00 K(+23.2%) |
| Mar 2023 | - | $104.00 K(+6.1%) | $388.00 K(+19.4%) |
| Dec 2022 | $325.00 K | $98.00 K(+4.3%) | $325.00 K(+21.7%) |
| Sep 2022 | - | $94.00 K(+2.2%) | $267.00 K(+4.3%) |
| Jun 2022 | - | $92.00 K(+124.4%) | $256.00 K(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $41.00 K(+2.5%) | $289.00 K(-7.4%) |
| Dec 2021 | $312.00 K(+225.0%) | $40.00 K(-51.8%) | $312.00 K(0.0%) |
| Sep 2021 | - | $83.00 K(-33.6%) | $312.00 K(+23.3%) |
| Jun 2021 | - | $125.00 K(+95.3%) | $253.00 K(+74.5%) |
| Mar 2021 | - | $64.00 K(+60.0%) | $145.00 K(+51.0%) |
| Dec 2020 | $96.00 K(+159.5%) | $40.00 K(+66.7%) | $96.00 K(+71.4%) |
| Sep 2020 | - | $24.00 K(+41.2%) | $56.00 K(+75.0%) |
| Jun 2020 | - | $17.00 K(+13.3%) | $32.00 K(+113.3%) |
| Mar 2020 | - | $15.00 K | $15.00 K |
| Dec 2019 | $37.00 K(+3600.0%) | - | - |
| Dec 2018 | $1000.00 | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual D&A year-on-year change?
- What is Tarsus Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly D&A year-on-year change?
- What is Tarsus Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM D&A year-on-year change?
What is Tarsus Pharmaceuticals annual depreciation & amortization?
The current annual D&A of TARS is $877.00 K
What is the all time high annual D&A for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual depreciation & amortization is $877.00 K
What is Tarsus Pharmaceuticals annual D&A year-on-year change?
Over the past year, TARS annual depreciation & amortization has changed by +$552.00 K (+169.85%)
What is Tarsus Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of TARS is $284.00 K
What is the all time high quarterly D&A for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly depreciation & amortization is $347.00 K
What is Tarsus Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, TARS quarterly depreciation & amortization has changed by -$63.00 K (-18.16%)
What is Tarsus Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of TARS is $1.14 M
What is the all time high TTM D&A for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM depreciation & amortization is $1.14 M
What is Tarsus Pharmaceuticals TTM D&A year-on-year change?
Over the past year, TARS TTM depreciation & amortization has changed by +$263.00 K (+29.99%)